F/m Emerald Life Sciences Innovation ETF Rating $29.66 -0.78 (-2.55%) Closing price 03:53 PM EasternExtended Trading$29.44 -0.22 (-0.74%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock F/m Emerald Life Sciences Innovation ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LFSC Aggregate RatingModerate Buy 2.76Holdings in LFSC have an aggregate rating of Moderate Buy based on 310 analyst ratings issued in the past year covering 25 companies (89.4% of the portfolio).LFSC Aggregate Price Target$29.82High Prediction$29.82Average Prediction$29.82Low Prediction$29.82Holdings in LFSC have an aggregate price target of $29.82 and a range of $29.82 to $29.82 covering 25 companies (89.4% of the portfolio).LFSC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy20 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by F/m Emerald Life Sciences Innovation ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 LFSC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.93%TVTXTravere Therapeutics$25.19-3.4%2.2736 of 5 stars2.73$35.21 39.8%15Analyst Forecast6.13%LIVNLivaNova$50.74-2.6%2.5898 of 5 stars2.50$59.71 17.7%8Analyst Forecast5.19%RDNTRadNet$70.65-3.0%3.3703 of 5 stars2.88$76.80 8.7%8Analyst Forecast4.97%TMDXTransMedics Group$107.29-5.0%3.2109 of 5 stars2.50$125.40 16.9%12Positive NewsAnalyst Forecast4.85%ETNB89BIO$14.82-0.4%2.9034 of 5 stars2.40$25.81 74.2%10Analyst ForecastHigh Trading Volume4.62%SLNOSoleno Therapeutics$63.67-2.9%4.3639 of 5 stars2.93$115.92 82.1%14Analyst Forecast4.62%NKTRNektar Therapeutics$54.22-2.6%4.04 of 5 stars2.63$91.67 69.1%8Analyst Forecast4.09%MDGLMadrigal Pharmaceuticals$429.85+0.4%4.3571 of 5 stars2.73$525.88 22.3%11Positive NewsAnalyst Forecast3.78%KALVKalVista Pharmaceuticals$11.47-2.9%3.7545 of 5 stars2.90$26.43 130.4%10Analyst Forecast3.70%BBIOBridgeBio Pharma$55.45+1.2%4.1007 of 5 stars2.89$63.94 15.3%18Analyst Forecast3.61%CORTCorcept Therapeutics$73.96-16.3%4.9065 of 5 stars2.57$135.25 82.9%7Analyst ForecastInsider Trade3.57%MMSIMerit Medical Systems$79.31-3.8%4.6793 of 5 stars2.89$107.50 35.5%9Positive NewsAnalyst Forecast3.56%GHGuardant Health$64.18-1.7%3.5224 of 5 stars2.92$65.86 2.6%24Analyst ForecastGap Up3.20%MIRMMirum Pharmaceuticals$72.82-1.4%3.1593 of 5 stars3.00$76.50 5.1%12Positive NewsAnalyst Forecast3.17%WVEWAVE Life Sciences$7.60-7.3%4.4375 of 5 stars2.81$20.33 167.7%16News CoverageAnalyst Forecast2.93%COGTCogent Biosciences$16.31+0.7%2.4076 of 5 stars2.77$20.00 22.7%13Analyst Forecast2.86%ATECAlphatec$13.16-4.4%4.2872 of 5 stars2.71$18.50 40.6%72.86%KRROKorro Bio$42.84-8.3%2.0105 of 5 stars3.00$86.83 102.7%8News CoveragePositive NewsHigh Trading Volume2.75%COLLCollegium Pharmaceutical$32.05-3.5%4.1359 of 5 stars3.00$42.33 32.1%5Analyst Forecast2.56%RAREUltragenyx Pharmaceutical$31.45-0.7%4.3341 of 5 stars2.77$81.50 159.2%13Positive NewsAnalyst Forecast2.35%INSMInsmed$162.56-1.1%3.1965 of 5 stars2.86$149.06 -8.3%21Analyst Forecast1.93%AXSMAxsome Therapeutics$121.75-0.6%4.713 of 5 stars3.00$177.93 46.1%17Trending NewsAnalyst ForecastInsider TradeAnalyst Revision1.74%ACADACADIA Pharmaceuticals$20.06-2.8%4.5264 of 5 stars2.65$29.12 45.2%20Analyst Revision1.70%UTHRUnited Therapeutics$439.41-1.3%4.3219 of 5 stars2.67$457.21 4.1%15Analyst ForecastInsider Trade1.69%ITGRInteger$101.00-2.3%3.8875 of 5 stars2.89$139.57 38.2%9News CoveragePositive NewsAnalyst Forecast This page (NASDAQ:LFSC) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenIf you're a futures trader (or want to be one), this could be the biggest shift you'll ever see in the prop fi...Neuro Street Trading Academy | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | SponsoredElon Warns “America Is Broke”. Trump’s Plan Inside.For the everyday American who's worked hard to build their nest egg, Trump preserved a IRS loophole that allow...American Hartford Gold | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding F/m Emerald Life Sciences Innovation ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share F/m Emerald Life Sciences Innovation ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
